Lazertinib Vs Osimertinib in 1L EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis from MARIPOSA
JOURNAL OF THORACIC ONCOLOGY(2024)
Key words
EGFR TKI,Lazertinib,NSCLC
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined